Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

The ALS/PDC syndrome of Guam and the cycad hypothesis

  • Amy R. Borenstein, University of South Florida, COPH, Epi and Biostat, 13201 Bruce B Downs Blvd., Tampa, FL 33612aborenst@health.usf.edu
  • James A. Mortimer, Gerard D. Schellenberg ( Philadelphia, PA) , Douglas Galasko ( San Diego, CA.)
Submitted July 25, 2008

In their review of the ALS/PDC syndrome of Guam, Steele and McGeer argue against the cycad hypothesis of causation, noting the persistence of this disorder after 1950 when the regular consumption of cycad flour (fadang) among the native Chamorros ceased. [1]

The rapid decline in incidence of both ALS and PDC beginning in the 1950s and persisting for more than 50 years is well established. [2] The occasional observation of new cases by Dr. Steele is consistent with a disappearing syndrome resulting from a point exposure in the 1940s. Analysis of the 29 cases of PDC identified in our 2003 island-wide prevalence study reveals that all subjects were born before 1940 and would have had ample opportunity to be exposed to an environmental toxin in the 1940s. [3]

Steele and McGeer state that our findings of an association of cycad exposure with PDC, MCI and Guam dementia (GD) “are inconsistent with any reasonable theory regarding fadang toxicity,” because of a protective effect of exposure in childhood and lack of association in adulthood. [1] We pointed out that the protective effect in childhood is likely due to recall bias related to study design. [4]

Our findings of significantly elevated odds ratios for picking, processing and eating fadang in early adulthood for all three outcomes (GD, MCI and PDC) are consistent with a point-source exposure. These findings are also consistent with epidemiologic evidence showing a preponderance of affected men as well as reflecting a commonality in causation of all three disorders. The fact that adult exposures were not associated is likely due to the rapid decline in exposure rates of Chamorros to cycad during the 1960s and later when subjects reached adulthood, reducing the statistical power to detect an effect. [4]

Long-term cycad toxicity is plausible, based on recent studies that implicate toxins other than BMAA. For example, phytosterol glucosides that result in the excitotoxic release of glutamate lead to motor neuron and Parkinsonian phenotypes and pathology in cycad extract-fed mice. [5]

While alternative hypotheses are welcome, there are negligible data to support them. Steele and McGeer suggest that an infection that causes retinopathy may predispose to ALS/PDC. [1] The infectious agent has never been identified, and there is no evidence that infectious retinal diseases trigger tangle formation in widespread regions of brain and spinal cord. Finally, the rapid decline in incidence is inconsistent with either a genetic or persisting environmental exposure.

References

1. Steele JC, McGeer PL. The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology 2008;70:1984-1990.

2. Plato CC, Garruto RM, Galasko D, et al. Amyotrophic lateral sclerosis and Parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. American Journal of Epidemiology 2003;157:149-157.

3. Galasko D, Salmon D, Gamst A et al. Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education and APOE. Neurology 2007;68:1772-1781.

4. Borenstein AR, Mortimer E, Schofield E et al. Cycad exposure and risk of dementia, MCI and PDC in the Chamorro population of Guam. Neurology 2007;68:1764-71.

5. Wilson J, Shaw CA. Commentary on: Return of the cycad hypothesis – does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health? Neuropathology and Applied Neurobiology 2006;32:341-343.

Disclosures: The authors have no disclosures

Navigate back to article

Neurology: 100 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise